Advertisement
Johnson & Johnson
Subscribe to Johnson & Johnson
View Sample

FREE Email Newsletter

TorkLaw Continuing to Accept DePuy ASR Hip Implant Cases

December 27, 2013 1:35 pm | by PR Newswire | News | Comments

In November 2013, Johnson & Johnson announced that it has agreed to pay at least $2.5 billion to settle nearly 8,000 DePuy Orthopaedics Hip Implant lawsuits which have been filed across the country.  It is estimated by some accounts...

DePuy Synthes Trauma Launches Radial Head Prosthesis System in the U.S.

December 13, 2013 7:15 pm | by PR Newswire | News | Comments

DePuy Synthes Trauma announces that it is launching the new Radial Head Prosthesis System for primary and revision joint replacement of the radial head to restore joint function. The System offers several benefits over current technologies...

FDA Reaches $1.25M Settlement with J&J Unit

December 6, 2013 9:33 am | by The Associated Press | News | Comments

The Food and Drug Administration said Wednesday that it reached a $1.25 million settlement with a division of Johnson & Johnson over allegations that it knowingly shipped faulty sterilization equipment used by hospitals. Under the civil...

Advertisement

Indian media accuses state of failing metal hip patients

December 6, 2013 7:29 am | by Mass Device | News | Comments

India media accused its government of failing to act to protect patients potentially harmed by Johnson & Johnson's now-recalled metal-on-metal hips. Mumbai's dna news source wrote this week that the state government "has turned a blind eye...

Did patients draw the short stick in $2.5B J&J metal hip settlement?

November 27, 2013 7:29 am | by Mass Device | News | Comments

When Johnson & Johnson (NYSE:JNJ) agreed to a $2.5 billion settlement to close some 8,000 cases over its metal-on-metal hip implants, about 1/3 of that money went to the lawyers and legal teams representing the cases. Lawyers took an...

J&J to Pay $2.5B to Settle Hip Replacement Suits

November 21, 2013 1:45 pm | by John Seewer and Matthew Perrone, Associated Press | News | Comments

Johnson & Johnson said late Tuesday that it will pay $2.5 billion to settle thousands of lawsuits brought by hip replacement patients who accuse the company of selling faulty implants that led to injuries and additional surgeries. The agreement...

New Digital Health Technology to Help Cancer Patients Wins Top Innovation Prize

November 21, 2013 8:48 am | by Business Wire | News | Comments

A start-up established by medical scientists that develops mobile apps for cancer patients has taken first place in the inaugural Digital Health Masterclass Challenge hosted by Janssen Healthcare Innovation and Johnson & Johnson Innovation...

Ethicon Announces Collaboration Agreement with MEGADYNE®

November 21, 2013 8:00 am | by Business Wire | News | Comments

Ethicon Endo-Surgery, Inc. (Ethicon) Energy business, market leaders in advanced energy surgical devices, today announced that it has entered into a collaboration agreement with MEGADYNE ®, market leaders in electrosurgery. Per the terms of the...

Advertisement

J&J Settlement Resolves Metal Hip Lawsuits But Weak Oversight Leaves Patients Vulnerable

November 19, 2013 6:11 pm | by The Associated Press | News | Comments

Johnson & Johnson announced today that it has reached a multi-billion dollar settlement for victims of the company's flawed all metal hip implant. The problems patients have experienced with the device demonstrate the need for stricter...

AHF: J&J’s $4 Billion Hip Lawsuit Settlement Shows Pharma’s Immense Wealth—and Greed

November 13, 2013 11:14 am | by Business Wire | News | Comments

As news of Johnson & Johnson’s plan to announce a $4 billion settlement to resolve over 7,500 federal and state lawsuits involving recalled J&J hip implant products spilled out earlier today via a Bloomberg news article, officials from...

Johnson & Johnson settles another DePuy ASR lawsuit

October 15, 2013 1:17 pm | by Mass Device | News | Comments

Johnson & Johnson settled another of the thousands of lawsuits it's facing over its recalled DePuy ASR metal-on-metal hip implant, according to court records. The lawsuit, MacDonald et al v. DePuy Orthopaedics Inc. et al, filed in the...

Depuy Synthes Spine Launches New 'mPACT' Program for Fixation and Fusion Procedures

October 11, 2013 11:26 am | by DePuy Synthes Spine | News | Comments

DePuy Synthes Spine* announced the global launch of "mPACT" (medialized Posterior Approach Cortical Trajectory), a program that combines implants, education, clinical research and procedural support for posterior mini open fixation and fusion...

Synflate Vertebral Balloon Designed For Osteoporotic Fractures

October 11, 2013 11:22 am | by DePuy Synthes Spine | News | Comments

DePuy Synthes Spine announced the launch of the new SYNFLATE Vertebral Balloon as part of its portfolio of procedural solutions for the treatment of painful vertebral compression fractures, internal breaks in spinal bones that commonly occur...

Advertisement

Therapeutic Coatings for Medical Device Implants

October 1, 2013 3:27 pm | by Nathan Lockwood, Ph.D., Senior Manager of R&D, SurModics Inc. | SurModics, Inc. | Articles | Comments

Drug delivery coatings are not a new technology to the medical device industry. However, as more implantable devices are tasked with achieving a greater level of healthcare, they do offer great benefit to design engineers. This article reviews drug coating technology and looks at application areas where it has made a significant impact.

Zimmer, Abbott, others rake in hundreds of millions in fed contracts

September 26, 2013 4:17 pm | by Mass Device | News | Comments

Federal agencies have handed out a slew of contracts and contract extensions in recent weeks, including about $370 million in deals for medical supplies and devices. The biggest takers were Becton Dickinson & Co., Johnson & Johnson, and Synthes, who together claimed more than half of the contract funding.

Instrumentation for Less Invasive Surgical Fixation of Rib Fractures

September 13, 2013 11:34 am | by DePuy Synthes | News | Comments

DePuy Synthes CMF, a leader in skeletal and soft tissue repair and reconstruction, announced the launch of new instrumentation that enables less invasive surgical fixation and stabilization of rib fractures with the company's MatrixRIB™ System of precontoured, low-profile titanium plates, locking screws and intramedullary splints.

Consumers Union Calls On Medical Device Makers to Provide Warranties for Hip & Knee Implants

September 10, 2013 9:01 am | by The Associated Press | News | Comments

Consumers Union is pushing device makers to equip patients with warranties so they will have a better understanding of how long an implant is expected to last and a clear process to follow in the event that it fails prematurely.  Ultimately, warranties will encourage companies to make their devices safer and more durable, according to Consumers Union.

Medinol goes after J&J's Cordis in stent patent war

August 28, 2013 9:29 am | by Mass Device | News | Comments

Cordis Corp., the stent-making arm of Johnson & Johnson, got out of the coronary stent game 2 years go, but that's not stopping Israeli medical device company Medinol from suing Cordis for patent infringement with the Cypher and Cypher Select stents it no longer makes.

Anapol Schwartz Now Investigating DePuy Limb Preservation System Recall

August 13, 2013 11:24 am | by The Associated Press | News | Comments

The Anapol Schwartz national law firm is now investigating the Class I recall of the Limb Preservation System (LPS) Lower Extremity Dovetail Intercalary Component issued by DePuy Orthopaedics on July 11, 2013. Patients who have suffered a LPS failure are encouraged to contact the firm...

Johnson & Johnson can exclude recall evidence in DePuy ASR bellwether lawsuit

August 9, 2013 1:13 pm | by Mass Device | News | Comments

Evidence of the recall of the DePuy ASR metal-on-metal hip implant can be excluded from a bellwether trial over the device, a federal judge ruled last month. Johnson & Johnson's DePuy Orthopaedics division pulled the DePuy ASR device from the market in 2010, prompting thousands of personal injury lawsuits across the country.

Cordis recall of Optease vena cava filter is Class I

August 8, 2013 12:01 pm | by Mass Device | News | Comments

The recall last March of Johnson & Johnson unit Cordis Corp.'s Optease vena cava filter is Class I, according to the FDA, meaning the device could cause serious injury or death. Cordis notified healthcare providers March 29 about 33,000 Optease devices, on concerns that they could be implanted backwards, according to the FDA.

J&J Pleased Chinese Anti-Monopoly Dispute Is Over

August 5, 2013 12:50 pm | by The Associated Press | News | Comments

Healthcare giant Johnson and Johnson says it is pleased to put a legal dispute behind it after a Chinese court ordered it to pay compensation to a former distributor under an anti-monopoly law. Thursday's ruling said Johnson & Johnson was guilty of "vertical monopoly" for setting minimum prices its distributors charged for surgical sutures.

China fines Johnson & Johnson in landmark price-fixing case

August 2, 2013 1:26 pm | by Mass Device | News | Comments

Johnson & Johnson (NYSE:JNJ) won the dubious distinction of being the 1st Fortune 500 company to be fined for price fixing in China, according to a newspaper there. The healthcare giant was fined 530,000 yuan (about $86,456) by the Shanghai High People's Court yesterday to compensate a former Chinese distributor, Rainbow Medical, China Daily reported.

ReVision Optics sees $55M funding round

July 29, 2013 12:11 pm | by Mass Device | News | Comments

ReVision Optics said it's raised $55 million from a consortium of investors and closed enrollment in a clinical trial of its Raindrop near vision inlay to treat presbyopia. The Lake Forest, Calif.-based company said all of its existing backers – Canaan Partners, ProQuest Investments, InterWest Partners and Domain Assoc. – were joined by new investors Johnson & Johnson Development Corp. and RusnanoMedInvest in the round.

Johnson & Johnson subsidiary gets Class I recall for implantable infusion pumps

July 25, 2013 11:29 am | by Mass Device | News | Comments

The FDA puts its highest-risk label on a recall of programmable infusion pumps made by Codman & Shurtleff Inc., a division of Johnson & Johnson subsidiary DePuy Orthopaedics. Codman's implanted MedStream pumps were recalled over a potential defect in a component that measures the contents of the pump reservoir.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading